Skip to main content

Lux Capital — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

402
Companies
$19.3B
Total invested
$61.1M
Avg. check
54
Industries
Health Care 8Biotechnology 7Medical 6Artificial Intelligence (AI) 6Software 4Therapeutics 4+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 402
SteadyMD
May 2023

SteadyMD is a B2B telehealth infrastructure provider that powers high-quality telehealth experiences for companies in all 50 states

Health Care · St LouisVenture - Series Unknown
Vendia
May 2022

Power AI with all your data. Turn your enterprise data, assets, and services into AI-powered outcomes seamlessly and securely.

Artificial Intelligence (AI) · San Francisco$30.0M Series B
H1.co
May 2026

H1 is on a mission to connect the world to the right doctor

Biotechnology · New YorkVenture - Series Unknown
Observable Space
May 2026

Observable Space provides sectors of the space industry, including commercial, science, education, and government users.

Analytics · Santa Monica$90.0M Series A
Context
May 2025

Context frees up teams to focus on higher-value strategies by drafting, analyzing, visualizing, and distributing work.

Information Technology · Palo Alto$11.0M Seed
Waypoint Bio
May 2026

Optimizing cell therapy with spatial biology

Biotechnology · New York$20.0M Series A
Miga
May 2022

Miga is a virtual cardiometabolic clinic that combines a gamified app (akin to Duolingo) with clinical services.

Fitness · San Francisco$12.0M Seed
A-Alpha Bio
May 2024

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

Biotechnology · Seattle$14.5M Grant
Senti Biosciences
May 2026

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

Biotechnology · South San Francisco$10.0M Post-IPO Debt
Neptune Mutual
May 2022

Neptune Mutual platform explores new avenues to creating user-centric hedging products on the blockchain.

Blockchain · Winchester$5.3M Venture - Series Unknown
Kallyope
May 2023

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Biotechnology · New York$8.2M Grant
Desktop Metal
May 2022

Desktop Metal is a provider of metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers.

3D Printing · Burlington$100.0M Post-IPO Debt
Privateer
April 2025

Privateer develops data infrastructure to power sustainable growth for the new space economy.

Big Data · KiheiCorporate Round
Applied Compute
April 2026

Applied Compute is an AI startup that builds custom AI models and Specific Intelligence solutions for enterprises.

Artificial Intelligence (AI) · San Francisco$80.0M Venture - Series Unknown
Biosynch.ai
April 2025

Pioneering the future of medicine through artificial intelligence and computational biology.

San Diego$4.2M Seed
Planet
April 2026

Planet is an aerospace and data analytics company that builds small satellites and delivers information about the changing planet.

Aerospace · San Francisco$108.0M Post-IPO Equity
Whisper Aero
April 2025

Whisper Aero manufactures ultra-quiet electric propulsion systems for drones and electric vertical take-off and landing (eVTOL) vehicles.

Aerospace · Crossville$500K Grant
Veo Robotics
April 2023

Veo Robotics develops smart device solutions to enable high performance collaborative industrial robotics.

Artificial Intelligence (AI) · Waltham$14.0M Series B
Durin
April 2025

Durin Mining Technologies builds autonomous drilling rigs to streamline and modernize mineral exploration processes.

Autonomous Vehicles · El Segundo$3.4M Pre-Seed
Xaira Therapeutics
April 2024

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Artificial Intelligence (AI) · South San Francisco$1.0B Series A
Octant Bio
April 2022

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Biotechnology · Los Angeles$80.0M Series B
Cala Health
April 2026

Cala Health is a bioelectronic medicine company that develops wearable neuromodulation devices for the treatment of chronic diseases.

Health Care · San Mateo$50.0M Debt Financing
Cognichip
April 2026

Cognichip is an AI-first deep tech company focused on transforming the semiconductor industry by revolutionizing how chips are designed.

AI Infrastructure · Redwood City$60.0M Series A
DeepSpin
April 2026

DeepSpin is a company developing an artificial intelligence-powered MRI imaging machine.

Artificial Intelligence (AI) · Berlin$2.6M Grant

Where Lux Capital invests

Health Care8
Biotechnology7
Medical6
Artificial Intelligence (AI)6
Software4
Therapeutics4

About Lux Capital's portfolio

How many companies has Lux Capital invested in?

Lux Capital has invested in 402 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Lux Capital invest in?

Lux Capital's top investment sectors include Health Care, Biotechnology, Medical, Artificial Intelligence (AI), Software. The firm invests across 54 different industry categories.

What is Lux Capital's largest investment?

Among tracked funding rounds, Xaira Therapeutics received $1.0B in a Series A round. Lux Capital's total known invested capital is $19.3B.

What is the average investment size for Lux Capital?

Lux Capital's average investment size is $61.1M across its portfolio of 402 companies.

What are Lux Capital's most recent investments?

Recent Lux Capital portfolio additions include SteadyMD, Vendia, H1.co, Observable Space, Context. These companies were founded in 2020 or later.

Reach the founders behind these 402 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →